Position in INCY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$561,812
New position
Shares Held
4,956
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#172
of 370 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026JUNCTURE WEALTH STRATEGIES, LLC holds $4,939,567 across 9 Biotechnology names. INCY ranks #6 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
11,865 | $928,673 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
10,577 | $862,765 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
34,232 | $580,917 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
18,408 | $578,563 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
4,815 | $563,692 | |
| 6 | INCY |
Incyte Corp
This page
|
4,956 | $561,812 | |
| 7 | VCEL |
Vericel Corp
|
8,283 | $368,510 | |
| 8 | TBPH |
Theravance Biopharma, Inc.
|
17,234 | $292,978 |
All Filings in INCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,812 | 4,956 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||